NYSE$XRN
Global Medical REIT Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Navigated challenging acquisitions and interest rate environment relying on portfolio quality and tenant base resilience.
Global Medical REIT reported a 13.7% year-over-year increase in rental revenue to $36.2 million for Q1 2023. Net income attributable to common stockholders was $0.7 million, or $0.01 per diluted share. The company focused on renewing expiring leases and leasing vacant space, and completed one acquisition in April 2023 for $6.7 million.
- Rental revenue increased 13.7% year-over-year to $36.2 million.
- Net income attributable to common stockholders totaled $0.7 million, or $0.01 per diluted share.
- FFO was $15.1 million, or $0.22 per share and unit, and AFFO was $16.0 million, or $0.23 per share and unit.
- Portfolio was 97.0% occupied with an annualized base rent of $114.9 million as of March 31, 2023.
Headline financials
Revenue & EPS history
Global Medical REIT · Revenue · Quarterly
$36.2M
Forward guidance
The company is well-positioned to ramp up acquisition activity when cap rate spreads return to an attractive level and markets normalize.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2023
+0.2%
Avg return
Earnings day
+0.9%
Avg return
5 days after
+1.1%
Avg return
30 days after
56%
22 / 39 earnings
Positive
+7.3%
Q4 2016
Best reaction
-9.8%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.2% | -4.2% | — | |
| Q4 2025 | -1.6% | -2.6% | -13.2% | |
| Q3 2025 | +1.8% | +3.2% | +1.7% | |
| Q1 2025 | -9.8% | -11.7% | -17.0% | |
| Q4 2024 | +3.8% | +4.4% | +3.1% | |
| Q3 2024 | -2.6% | -3.6% | -7.4% | |
| Q2 2024 | -1.8% | -0.3% | +1.0% | |
| Q1 2024 | +3.4% | +4.8% | +8.4% | |
| Q4 2023 | -5.6% | -2.7% | -5.7% | |
| Q3 2023 | -1.8% | -0.8% | +11.7% | |
| Q2 2023 | +3.5% | +4.8% | -1.5% | |
| Q1 2023 | +0.8% | +1.8% | +1.9% | |
| Q4 2022 | -4.0% | -1.2% | -13.0% | |
| Q3 2022 | -0.9% | +0.2% | +12.3% | |
| Q2 2022 | -0.5% | -1.3% | -11.0% | |
| Q1 2022 | -5.3% | -11.9% | -12.5% | |
| Q4 2021 | -3.2% | -2.2% | +1.9% | |
| Q3 2021 | +1.6% | +1.0% | -2.5% | |
| Q2 2021 | -0.7% | -0.2% | +3.7% | |
| Q1 2021 | -1.2% | +1.0% | +5.2% | |
| Q4 2020 | +1.6% | +3.9% | +0.2% | |
| Q3 2020 | +2.0% | +1.4% | +7.2% | |
| Q2 2020 | +4.8% | +11.4% | +11.6% | |
| Q1 2020 | +7.0% | +9.3% | +26.0% | |
| Q4 2019 | +4.7% | -7.2% | -41.1% | |
| Q3 2019 | +2.3% | +9.5% | +22.4% | |
| Q2 2019 | -0.7% | +1.8% | +5.0% | |
| Q1 2019 | +1.4% | +4.5% | +7.1% | |
| Q4 2018 | +0.8% | +2.6% | -2.0% | |
| Q3 2018 | +2.2% | +2.0% | +6.4% | |
| Q2 2018 | +4.3% | +6.7% | +12.2% | |
| Q1 2018 | +2.6% | -0.1% | +4.6% | |
| Q4 2017 | +5.8% | +6.3% | +3.9% | |
| Q3 2017 | +3.1% | +3.7% | -2.8% | |
| Q2 2017 | +0.7% | +2.8% | +2.8% | |
| Q1 2017 | -1.2% | +0.0% | +0.3% | |
| Q4 2016 | +7.3% | +9.3% | +17.1% | |
| Q3 2016 | -8.5% | -14.9% | -0.2% | |
| Q2 2016 | +1.1% | +2.3% | -5.0% | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — | |
| Q2 2012 | — | — | — | |
| Q1 2011 | — | — | — | |
| Q4 2011 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro